Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
SISCAPA Assay Technologies, a provider of high-sensitivity protein quantitation, and Biognosys, a provider of next-generation proteomics, announced an exclusive strategic collaboration to offer biopharma customers a streamlined end-to-end solution ...
read more
Thursday, November 01, 2018
Sirona Dx announced the introduction of Imaging Mass Cytometry services on the Fluidigm Hyperion Imaging System to advance biomarker discovery and therapeutic development.
read more
Thursday, November 10, 2016
Sirona Dx, a supplier of high complexity genomics and proteomics services, has adopted Thermo Fisher Scientific’s Oncomine Focus Assay to run on the Ion PGM System and will expand its drug development and next generation sequencing (NGS) services ...
read more
Sirnaomics and PNI jointly announced a partnership on the development and manufacture of Sirnaomics polypeptide nanoparticle-based RNAi therapeutic product.
read more
Wednesday, January 08, 2020
Sirnaomics and Innovent Biologics announced they have entered a strategic collaboration to conduct clinical studies, using STP705 and Tyvyt.
read more
Tuesday, October 03, 2017
SIRION Biotech GmbH and Vibalogics GmbH, have signed a strategic partnership agreement designed to meet demand from gene therapy companies for a start-to-finish AAV service.
read more
SIRIO Pharma has reported record revenues in the APAC (excluding China) region, with construction set to begin on a major new manufacturing facility in Thailand in Q4 2025. Growth has been driven by rising demand across Southeast Asia, with key ...
read more
Monday, September 08, 2025
SIRIO Pharma announced that its Ma’anshan facility in China has been granted a Certificate of GMP Compliance by the Therapeutic Goods Administration (TGA) of Australia.
read more
Thursday, October 18, 2018
Sirio Pharma announces the opening of a gummy production plant at its new development and manufacturing facility in Ma’anshan, China.
read more
Sirio Pharma announced the appointment of Mark Dewis as General Manager of the Sirio Americas Business Unit. Dr. Dewis brings more than 30 years of experience in the food, beverage, and nutritional supplement industries.
read more
Tuesday, January 10, 2023
Sirio Pharma Co., Ltd. has completed the acquisition of a majority stake in Best Formulations LLC, a contract manufacturer of Nutritional Supplements and Personal Care products based in California.
read more
Tuesday, October 15, 2024
SIRIO Pharma has invested €16 million in a dedicated and purpose-built packaging facility, with automated packaging lines, at its Pritzwalk campus near Berlin, Germany.
read more
SIRIO Pharma announced the launch of the Sirio Institute for Anti-Ageing (SIA) at the 2025 Boao Health Food Science Conference and Expo. The Institute aims to advance anti-ageing science and accelerate the development and commercialization of ...
read more
Wednesday, September 20, 2017
Synthego has announced the appointment of Sir Andrew Witty, former CEO of GlaxoSmithKline and Director at UnitedHealth Group, to the Synthego advisory board.
read more
Monday, November 06, 2017
Gattefossé USA and Gattefossé Canada announce their partnership with SIO to bring highly refined USP/NF grade injectable oils to the North American pharmaceutical product development market.
read more